Great Lakes Retirement Inc. bought a new stake in shares of Becton Dickinson and Co (NYSE:BDX) during the fourth quarter, HoldingsChannel reports. The fund bought 5,502 shares of the medical instruments supplier’s stock, valued at approximately $1,502,000.
A number of other large investors also recently made changes to their positions in BDX. Wealth Quarterback LLC acquired a new stake in Becton Dickinson and during the 4th quarter valued at $7,588,711,000. Massachusetts Financial Services Co. MA grew its holdings in Becton Dickinson and by 48.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,201,008 shares of the medical instruments supplier’s stock valued at $870,578,000 after buying an additional 1,048,680 shares during the last quarter. Prudential Financial Inc. grew its holdings in Becton Dickinson and by 230.3% during the 4th quarter. Prudential Financial Inc. now owns 815,121 shares of the medical instruments supplier’s stock valued at $221,689,000 after buying an additional 568,366 shares during the last quarter. M&G Investment Management Ltd. acquired a new stake in Becton Dickinson and during the 4th quarter valued at $147,349,000. Finally, FMR LLC grew its holdings in Becton Dickinson and by 4.1% during the 4th quarter. FMR LLC now owns 13,465,704 shares of the medical instruments supplier’s stock valued at $3,662,267,000 after buying an additional 528,037 shares during the last quarter. Hedge funds and other institutional investors own 85.37% of the company’s stock.
In related news, EVP Simon D. Campion sold 8,085 shares of Becton Dickinson and stock in a transaction on Tuesday, February 4th. The stock was sold at an average price of $285.09, for a total value of $2,304,952.65. Following the transaction, the executive vice president now owns 11,296 shares in the company, valued at $3,220,376.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Claire Fraser sold 1,500 shares of Becton Dickinson and stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $258.72, for a total value of $388,080.00. The disclosure for this sale can be found here. Insiders sold 109,208 shares of company stock worth $30,137,672 in the last quarter. 0.12% of the stock is owned by insiders.
BDX has been the topic of a number of analyst reports. Citigroup began coverage on Becton Dickinson and in a report on Wednesday, March 4th. They set a “neutral” rating and a $260.00 target price on the stock. Raymond James cut Becton Dickinson and from a “strong-buy” rating to an “outperform” rating and decreased their price objective for the stock from $288.00 to $283.00 in a report on Friday, February 7th. Wells Fargo & Co decreased their price objective on Becton Dickinson and from $285.00 to $279.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Piper Sandler raised their price objective on Becton Dickinson and from to and gave the stock an “overweight” rating in a report on Thursday, February 6th. Finally, TheStreet cut Becton Dickinson and from a “b” rating to a “c+” rating in a report on Monday, March 9th. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $278.00.
Becton Dickinson and stock traded down $0.51 during midday trading on Wednesday, reaching $202.34. The stock had a trading volume of 41,774 shares, compared to its average volume of 2,940,433. Becton Dickinson and Co has a twelve month low of $197.75 and a twelve month high of $286.72. The stock has a market capitalization of $54.39 billion, a PE ratio of 74.57, a price-to-earnings-growth ratio of 1.83 and a beta of 1.14. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.55 and a current ratio of 0.96. The stock’s 50-day simple moving average is $244.92 and its 200 day simple moving average is $256.77.
Becton Dickinson and (NYSE:BDX) last issued its earnings results on Thursday, February 6th. The medical instruments supplier reported $2.65 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.63 by $0.02. Becton Dickinson and had a return on equity of 15.50% and a net margin of 4.96%. The firm had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.19 billion. During the same quarter last year, the firm earned $2.70 earnings per share. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. Equities analysts predict that Becton Dickinson and Co will post 11.96 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 10th will be issued a $0.79 dividend. This represents a $3.16 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date of this dividend is Monday, March 9th. Becton Dickinson and’s payout ratio is currently 27.05%.
Becton Dickinson and Company Profile
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems.
See Also: Relative Strength Index
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.